GENE ONLINE|News &
Opinion
Blog

2025-11-29|

Study Examines Incidence and Risk Factors of Catheter-Related Thrombosis in Pediatric Cancer Patients

by GOAI
Share To

A recent study has examined the incidence and characteristics of catheter-related thrombosis in pediatric cancer patients, offering new insights into this condition. Conducted as a single-center retrospective cohort study, the research focused on children diagnosed with malignant tumors who required central venous catheters (CVCs) as part of their treatment. The study aimed to better understand the frequency, risk factors, and clinical outcomes associated with catheter-related thrombosis in this vulnerable population.

The research team, which included Chen, Lin, and Shen, analyzed data from pediatric oncology patients to identify patterns and trends related to thrombosis development. The findings highlighted key aspects such as the prevalence of catheter-related thrombosis among children with cancer and potential contributing factors linked to its occurrence. By documenting these cases in detail, the study provides valuable information for healthcare professionals managing central venous access in pediatric oncology settings. Further details about the methodology and specific results were not disclosed in the initial report but are expected to contribute significantly to improving patient care strategies.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 30, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top